SeaSpine Corporation (SPNE)
NASDAQ: SPNE
· Real-Time Price · USD
9.54
0.73 (8.29%)
At close: Jan 04, 2023, 10:00 PM
SeaSpine Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|
| Orthobiologics Revenue | 91.82M | 78.38M | 81.3M | 75.34M | 69.13M | 66.24M | 67.26M |
| Orthobiologics Revenue Growth | +17.15% | -3.59% | +7.91% | +8.98% | +4.36% | -1.51% | n/a |
| Spinal Fusion Hardware Revenue | 99.63M | 75.96M | 77.78M | 68.1M | 62.69M | 62.62M | 65.92M |
| Spinal Fusion Hardware Revenue Growth | +31.16% | -2.34% | +14.21% | +8.64% | +0.11% | -5.01% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|
| Orthobiologics Revenue | 91.82M | 78.38M | 81.3M |
| Orthobiologics Revenue Growth | +17.15% | -3.59% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 47.75M | 45.22M | 40.45M | 41.77M | 39.22M | 35.42M | 33.83M | 34.22M | 31.07M | 25.86M | 29.03M | 32.78M | 30.93M | 28.4M | 28.1M | 28.45M | 27.04M | 25.43M | 24.47M | 26.2M | 24.47M | 25.04M | 24.76M | 25.69M | 24.76M | 28.27M | 26.66M | 28.77M | 27.64M | 33.02M | 26.45M |
| Selling, General, and Administrative Revenue Growth | +5.59% | +11.81% | -3.18% | +6.51% | +10.72% | +4.72% | -1.15% | +10.13% | +20.16% | -10.93% | -11.44% | +6.00% | +8.89% | +1.07% | -1.22% | +5.20% | +6.33% | +3.94% | -6.62% | +7.10% | -2.30% | +1.13% | -3.62% | +3.77% | -12.42% | +6.06% | -7.36% | +4.09% | -16.28% | +24.84% | n/a |
| Research and Development Revenue | 6.6M | 5.65M | 5.85M | 6.39M | 6.26M | 4.85M | 4.51M | 4.47M | 3.92M | 3.97M | 3.9M | 4.13M | 3.9M | 3.59M | 3.51M | 3.27M | 3.2M | 2.79M | 2.79M | 2.95M | 2.83M | 3.34M | 3.05M | 2.91M | 2.6M | 3.18M | 2.75M | 2.38M | 2.36M | 2.03M | 1.58M |
| Research and Development Revenue Growth | +16.76% | -3.44% | -8.42% | +2.01% | +29.11% | +7.63% | +0.76% | +14.17% | -1.43% | +2.03% | -5.69% | +6.01% | +8.61% | +2.14% | +7.24% | +2.25% | +14.76% | +0.07% | -5.52% | +4.16% | -15.25% | +9.64% | +4.88% | +11.85% | -18.26% | +15.55% | +15.67% | +0.68% | +16.63% | +28.13% | n/a |
| Sales and Marketing Revenue | 32.98M | 33.03M | 29.51M | 30.89M | 27.58M | 25.44M | 23.4M | 24.65M | 22.16M | 17.01M | 20.48M | 83.44M | 792K | 793K | 792K | n/a | n/a | n/a | n/a | 792K | 792K | 792K | 792K | 792K | 955K | 1.28M | 1.28M | 1.28M | 1.29M | 1.36M | n/a |
| Sales and Marketing Revenue Growth | -0.14% | +11.94% | -4.47% | +12.00% | +8.42% | +8.71% | -5.08% | +11.23% | +30.27% | -16.91% | -75.46% | +10435.98% | -0.13% | +0.13% | n/a | n/a | n/a | n/a | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | -17.07% | -25.45% | 0.00% | -0.08% | -1.00% | -4.57% | n/a | n/a |